Skip to main content
SpringerLink
Log in

Sex Hormones and Neoplasia: Liver Tumors in Rodents

  • Conference paper
Mouse Liver Tumors

Part of the book series: Archives of Toxicology ((TOXICOLOGY,volume 10))

Abstract

The association of liver tumors in women and men with the use of oral contraceptives and anabolics, respectively, has drawn attention to the hepatotumorigenic effects of sex hormones.

The available evidence from long-term carcinogenicity studies in various strains of mice, rats and hamsters indicates that sex hormones are hepatotumorigenic agents, although the incidence of liver tumors is, in general, low even at doses exceeding human exposure by a factor of one hundred or more. Among the three rodent species, mice appear to be the least sensitive. Under certain modulating conditions, however, a 100% incidence of hepatocellular carcinomas can be obtained with some estrogens in male Syrian golden hamsters.

The mechanism of the hepatotumorigenic effect of sex hormones is far from being clear. Whereas their tumor promoting activity is generally recognized, there is recent evidence suggesting that some sex hormones may also have initiating potential. Although the incomplete understanding of the mechanisms responsible for sex hormone induced liver neoplasia seriously hampers the assessment of the human risk, it appears to be clear that sex hormones are important modulating factors determining the incidence of hepatic tumors in rodents and possibly in humans.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Abbreviations

AT:

aminotriazole, 3-amino-1H-1,2,4-triazole

7,8-BF:

7,8-benzoflavone

CB-154:

2-bromoergocryptine

DEN:

diethylnitrosamine

DES:

diethylstilbestrol, 3,4-di(p-hydroxyphenyl)hex(3)ene

E2 :

estradiol-17β

EE2 :

17α-ethinyl estradiol

HCA:

hepatocellular adenoma

HCC:

hepatocellular carcinoma

NBU:

N-nitrosobutylurea

s.c.:

subcutaneous.

References

  • Barrows GH, Christopherson WM, Drill VA (1977) Liver lesions and oral contraceptive steroids. J Toxicol Environ Health 3: 219–230

    Article  PubMed  CAS  Google Scholar 

  • Baum JK, Holtz F, Bookstein JJ, Klein EW (1973) Possible association between benign hepatomas and oral contraceptives. Lancet 2: 926–929

    Article  PubMed  CAS  Google Scholar 

  • Brooks JJ (1982) Hepatoma associated with diethylstilbestrol therapy for prostatic cancer. J Urol 128: 1044–1045

    PubMed  CAS  Google Scholar 

  • Cameron RG, Imaida K, Tsuda H, Ito N (1982) Promotive effects of steroids and bile acids on hepatocarcinogenesis initiated by diethylnitrosamine. Cancer Res 42: 2426–2428

    PubMed  CAS  Google Scholar 

  • Colby HD (1980) Regulation of hepatic drug and steroid metabolism by androgens and estrogens. In: Thomas JA, Singhai R (eds) Advances in Sex Hormones, vol 4. Urban and Schwarzenberg, Baltimore, pp 27–73

    Google Scholar 

  • Committee on Safety of Medicines (1972) Carcinogenicity tests of oral contraceptives. Her Majesty’s Stationary Office, London

    Google Scholar 

  • Degen GH, Metzler M (1986) Sex hormones and neoplasia: genotoxic effects in short-term assays. Arch Toxicol 10: 264–278

    Google Scholar 

  • Ding L, Zou DY, Wang JT, Wang YB, Pan SR, Wand SH (1984) Histological study of the promotive effect of diethylstilbestrol on diethylnitrosamine initiated carcinogenesis of liver in rat. Pathol Res Pract 178: 339–344

    PubMed  CAS  Google Scholar 

  • Eisenfeld AJ, Aten RF, Weinberger MJ (1978) Oral contraceptives: possible mediation of side effects via an estrogen receptor in liver. Biochem Pharmacol 27: 2571–2575

    Article  PubMed  CAS  Google Scholar 

  • Evans DJ (1978) Liver tumors elicited by specific factors: synthetic androgens and anabolic steroids. In: Remmer H, Bolt HM, Bannasch P, Popper H (eds) Primary Liver Tumors. MTP Press, Lancaster, pp 213–216

    Google Scholar 

  • Firminger HJ, Reuber MD (1961) Influence of adrenocortical, androgenic, and anabolic hormones on the development of carcinoma and cirrhosis of the liver in A x C rats fed N-2-fluorenyldiacetamide. J Natl Cancer Inst 27: 559–595

    PubMed  CAS  Google Scholar 

  • Fisher B, Gunduz N, Saffer EA, Zheng S (1984) Relation of estrogen and its receptor to rat liver growth and regeneration. Cancer Res 44: 2410–2415

    PubMed  CAS  Google Scholar 

  • Gibson JP, Newberne JW, Kuhn WL, Elsa RJ (1967) Comparative chronic toxicity of three oral estrogens in rats. Toxicol Appl Pharmacol 11: 489–510

    Article  PubMed  CAS  Google Scholar 

  • Griffin MJ, Phillips DC (1982) Estradiol suppresses 2-AAF hepatocarcinogenesis in male Sprague Dawley rats. Proc Am Assoc Cancer Res 23: 233

    Google Scholar 

  • Heston WE, Vlahakis G, Desmukes B (1973) Effects of the antifertility drug Enovid in five strains of mice, with particular regard to carcinogenesis. J Natl Cancer Inst 51: 209 - 224

    PubMed  CAS  Google Scholar 

  • Higashi S (1981) Hepatocellular carcinoma induced by estrogen and progestogen: development of hepatocellular carcinoma in rats following oral administration of synthetic estrogen and progestogen. Mie Med J 30: 295–303

    CAS  Google Scholar 

  • Highman B, Greenman DL, Norvell MJ, Farmer J, Shellenberger TE (1980) Neoplastic and preneoplastic lesions induced in female C3H mice by diets containing diethylstilbestrol or 17ß-estra- diol. J Environ Pathol Toxicol 4: 81–95

    PubMed  CAS  Google Scholar 

  • Hoover R, Fraumeni JF (1981) Drug induced cancer. Cancer 47: 1071–1080

    Article  PubMed  CAS  Google Scholar 

  • I ARC (1979) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol 21: Sex Hormones ( I I ). International Agency for Research on Cancer, Lyon (France)

    Google Scholar 

  • Klein KM (1979) Oral contraceptive administration and hepatocellular neoplasms in the rat: Preliminary results. Gastroenterology 76: 1288

    Google Scholar 

  • Li JJ, Li SA (1984 a) Estrogen-induced tumorigenesis in hamsters: roles for hormonal and carcinogenic activities. Arch Toxicol 55: 110–118

    Google Scholar 

  • Li JJ, Li SA (1984 b) High incidence of hepatocellular carcinomas after synthetic estrogen administration in Syrian hamsters fed a-naphthoflavone: a new tumor model. J Matl Cancer Inst 73: 543–548

    Google Scholar 

  • Mackinnon M, Sutherland E, Simon FR (1977) Effects of ethinyl estradiol on hepatic microsomal proteins and the turnover of cytochrome P-450. J Lab Clin Med 90: 1096 - 1106

    PubMed  CAS  Google Scholar 

  • McLachlan JA, Korach KS, Newbold RR, Degen GH (1984) Diethylstilbestrol and other estrogens in the environment. Fund Appl Toxicol 4: 686–691

    Article  CAS  Google Scholar 

  • Mastri C, Lucier G (1985) Actions of hormonally active chemicals in the liver. In: Thomas JA, Korach KS, McLachlan JA (eds) Endocrine Toxicology. Target Organ Toxicology Series. Raven Press, New York, pp 335–355

    Google Scholar 

  • Mays ET, Christopherson W (1984) Hepatic tumors induced by sex steroids. Semin Liver Dis 4:147– 157

    Google Scholar 

  • McKinney GR, Weikel JH, Webb WK, Dick RG (1968) Use of the lifetable technique to estimate effects of certain steroids on probability of tumor formation in a long-term study in rats. Toxicol Appl Pharmacol 12: 68–79

    Article  PubMed  CAS  Google Scholar 

  • Mitznegg P, Schwarzlose W, Estler CH, Hach B, Heim F (1971) Der Einfluss einer peroral verabreich¬ten Oestrogen-Gestagen-Kombination auf das Wachstum und den Stoffwechsel von Leber und Nieren junger weiblicher Ratten. Klin Wschr 49: 615–617

    Article  PubMed  CAS  Google Scholar 

  • Newberne PM, Williams G (1969) Inhibition of aflatoxin carcinogenesis by diethylstilbestrol in male rats. Arch Environ Health 19: 489–498

    PubMed  CAS  Google Scholar 

  • Noble RC (1977) The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 37: 1929–1933

    PubMed  CAS  Google Scholar 

  • Noronha RFX, Goodall CM (1983) Enhancement by testosterone of dimethylnitrosamine carcinogenesis in lung, liver and kidney of inbred NZR/Gd female rats. Carcinogenesis 4: 613–616

    Article  PubMed  CAS  Google Scholar 

  • Ochs H, Düsterberg B, Günzel P, Schulte-Hermann R (1986) Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver. Cancer Res 46: 1224–1232

    PubMed  CAS  Google Scholar 

  • Paradinas FJ, Bull TB, Westaby D, Murray-Lyon IM (1977) Hyperplasia and prolapse of hepatocytes into hepatic veins during longterm methyltestosterone therapy: possible relationships of these changes to the development of peliosis hepatitis and liver tumours. Histopathology 1: 225–246

    Article  PubMed  CAS  Google Scholar 

  • Poel WE (1966) Pituitary tumors in mice after prolonged feeding of synthetic progestins. Science 154: 402–403

    Article  PubMed  CAS  Google Scholar 

  • Reuber MD, Firminger HI (1962) Effect of progesterone and diethylstilbestrol on hepatic carcinogenesis and cirrhosis in A x C rats fed N-2-fluorenyldiacetamide. J Natl Cancer Inst 29: 933–943

    PubMed  CAS  Google Scholar 

  • Reznik-Schüller H (1979) Carcinogenic effects of diethylstilbestrol in male Syrian golden hamsters and European hamsters. J Natl Cancer Inst 62: 1083–1088

    PubMed  Google Scholar 

  • Rieche K (1967) Langzeitbehandlung mit „Anovlar bei mammacarcinombelasteten Inzuchtmäusen. Arch Geschwulstforsch 29: 158–162

    PubMed  CAS  Google Scholar 

  • Rumbaugh RC, McCoy Z, Lucier GW (1984) Correlation of hepatic cytosolic androgen binding pro¬teins with androgen induction of hepatic microsomal ethylmorphine N-demethylase in the rat. J Steroid Biochem 21: 243–252

    Article  PubMed  CAS  Google Scholar 

  • Schardein JL, Kaump DH, Woosley ET, Jellema MM (1970) Long-term toxicologic and tumorigenesis studies on an oral contraceptive agent in albino rats. Toxicol Appl Pharmacol 16: 10–23

    Article  PubMed  CAS  Google Scholar 

  • Schardein JL (1980 a) Studies of the components of an oral contraceptive agent in albino rats. 1. Estrogenic component. J Toxicol Environ Health 6: 885–894

    Google Scholar 

  • Schardein JL (1980 b) Studies of the components of an oral contraceptive agent in albino rats. 2. Pro- gestogenic component and comparison of effects of the components and the combined agent. J Toxicol Environ Health 6: 895–906

    Google Scholar 

  • Schulte-Hermann R, Timmermann-Trosiener I, Schuppler J (1983) Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Research 43: 839–844

    PubMed  CAS  Google Scholar 

  • Schuppler J, Günzel P (1979) Liver tumors and steroid hormones in rats and mice. Arch Toxicol Suppl 2: 181–195

    PubMed  Google Scholar 

  • Schwarzlose W, Heim F (1970) The anabolic effects of estrogens on mouse liver and their inhibition by clomiphene. Biochem Pharmacol 19: 23–26

    Article  PubMed  CAS  Google Scholar 

  • Shar SR, Kew MC (1982) Oral contraceptives and hepatocellular carcinoma. Cancer 49: 407–110

    Article  PubMed  CAS  Google Scholar 

  • Sherlock S (1980) Hepatic effects of steroid sex hormones. In: Farber E, Fisher MM (eds) Toxic Injury of the Liver. Marcel Dekker, New York, pp 597–627

    Google Scholar 

  • Shimkin MB, Grady HG (1941) Toxic and carcinogenic effects of stilbestrol in strain C3H male mice. J Natl Cancer Inst 2: 55–60

    CAS  Google Scholar 

  • Stob M (1983) Naturally occurring food toxicants: estrogens. In: Recheige M (ed) CRC Handbook of Naturally Occurring Food Toxicants. CRC Press, New York, pp 81–100

    Google Scholar 

  • Sumi C, Yokoro K, Matsushima R (1983 a) Induction of hepatic tumors by diethylstilbestrol alone or in synergism with N-nitrosobutylurea in castrated male WF rats. J Natl Cancer Inst 70: 937–942

    Google Scholar 

  • Sumi C, Yokoro K, Matsushima R (1983 b) Suppression of diethylstilbestrol and N-nitrosobutylurea- induced mammary and pituitary tumorigenesis in rats by prolonged treatment with 2-bromoergo- criptine. Cancer Res 43: 4781–4785

    Google Scholar 

  • Sumi C, Yokoro K, Matsushima R (1984 a) Inhibitory effect of antiestrogen on hepatic tumorigenesis in WF rats treated with diethylstilbestrol alone or in combination with N-nitrosobutylurea. J Natl Cancer Inst 72: 949–953

    Google Scholar 

  • Sumi C, Yokoro K, Matsushima R ( 1984 b) Effects of 17-Restradiol and diethylstilbestrol on concurrent development of hepatic, mammary, and pituitary tumors in WF rats: Evidence for differential effect on liver. J Natl Cancer Inst 73: 1229–1234

    Google Scholar 

  • Sumi C, Yokoro K, Matsushima R (1985) Inhibition by 3-amino-lH-l,2,4-triazole of hepatic tumori¬genesis induced by diethylstilbestrol alone or combined with N-nitrosobutylurea in WF rats. J Natl Cancer Inst 74: 1329–1334

    PubMed  CAS  Google Scholar 

  • Sweeney GD, Cole FM (1980) Effects of ethinyl estradiol on liver microsomal mixed function oxyge¬nase activity in male rats. Lab Invest 42: 231–235

    PubMed  CAS  Google Scholar 

  • Taper HS (1978) The effect of estradiol-17-phenylpropionate and estradiol benzoate on N-nitrosomorpholine-induced liver carcinogenesis in ovariectomized female rats. Cancer 42: 462–467

    Article  PubMed  CAS  Google Scholar 

  • Taylor W, Snowball S, Lesna M (1984) The effects of long-term administration of methyltestosterone on the development of liver lesions in BALB/c mice. J Pathol 143: 211–218

    Article  PubMed  CAS  Google Scholar 

  • Vesselinovitch SD, Mihailovich N (1982) Modifying effects of synthetic steroids on the development of liver tumors induced by diethylnitrosamine. Proc Am Assoc Cancer Res 23: 91

    Google Scholar 

  • Wanless IR, Medline A (1982) Role of estrogens as promoters of hepatic neoplasia. Lab Invest 46:313- 320

    Google Scholar 

  • Yager JD (1983) Promotion of hepatic neoplasia by gonadal steroids. In: Slaga TJ (ed) Mechanisms of Tumor Promotion, vol 1. CRC Press, Boca Raton, pp 55–70

    Google Scholar 

  • Yager JD, Yager R (1980) Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res 40: 3680–3685

    PubMed  CAS  Google Scholar 

  • Yager JD, Campbell HA, Longnecker DS, Roebuck BD, Benoit MC (1984) Enhancement of hepatocarcinogenesis in female rats by ethinyl estradiol and mestranol but not estradiol. Cancer Res 44: 3862–3869

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Strasse 9, D-8700, Würzburg, Germany

    M. Metzler & G. H. Degen

Authors
  1. M. Metzler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. H. Degen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pharmacology and Therapeutics, Trinity College, University of Dublin, Dublin 2, Ireland

    Philip L. Chambers

  2. Institut für Toxikologie und Pharmakologie, der Universität Würzburg, Versbacher Landstraße 9, 8700, Würzburg, Germany

    Dietrich Henschler

  3. Institut für Toxikologie, der Universität Mainz, Obere Zahlbacher Straße 67, 6500, Mainz, Germany

    Franz Oesch

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag

About this paper

Cite this paper

Metzler, M., Degen, G.H. (1987). Sex Hormones and Neoplasia: Liver Tumors in Rodents. In: Chambers, P.L., Henschler, D., Oesch, F. (eds) Mouse Liver Tumors. Archives of Toxicology, vol 10. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71617-1_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71617-1_23

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-17124-9

  • Online ISBN: 978-3-642-71617-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation